Medicare announced it will now pay for a new molecular tissue test for idiopathic pulmonary fibrosis, called the Envisia Genomic Classifier (Veracyte).
New tissue test for idiopathic pulmonary fibrosis changes the diagnostic game
New tissue test for idiopathic pulmonary…
New tissue test for idiopathic pulmonary fibrosis changes the diagnostic game
Medicare announced it will now pay for a new molecular tissue test for idiopathic pulmonary fibrosis, called the Envisia Genomic Classifier (Veracyte).